Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells.

These results suggest that aggressive recurrence of breast cancer after chemotherapy might be suppressed in part with aspirin, which appears to disrupt the de novo generation of chemoresistant cancer stem-like cells.